Bonnet-Dechaume-Blanc syndrome: Difference between revisions
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
== Epidemiology == | == Epidemiology == | ||
== Diagnosis == | == Diagnosis == | ||
== Treatment == | == Treatment == | ||
The treatment for Bonnet–Dechaume–Blanc syndrome is controversial due to a lack of consensus on the different therapeutic procedures for treating arteriovenous malformations.<ref name=":7">{{cite journal|last1=Schmidt|first1=D|last2=Pache|first2=M|last3=Schumacher|first3=M|title=The congenital unilateral retinocephalic vascular malformation syndrome (bonnet-dechaume-blanc syndrome or wyburn-mason syndrome): review of the literature.|journal=Survey of ophthalmology|date=2008|volume=53|issue=3|pages=227–49|pmid=18501269}}</ref> The first successful treatment was performed by Morgan et al.<ref name=":8">{{cite journal|last1=Bhattacharya|first1=JJ|last2=Luo|first2=CB|last3=Suh|first3=DC|last4=Alvarez|first4=H|last5=Rodesch|first5=G|last6=Lasjaunias|first6=P|title=Wyburn-Mason or Bonnet-Dechaume-Blanc as Cerebrofacial Arteriovenous Metameric Syndromes (CAMS). A New Concept and a New Classification.|journal=Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences|date=30 March 2001|volume=7|issue=1|pages=5–17|pmid=20663326}}</ref> They combined intracranial resection, ligation of ophthalmic artery, and selective arterial ligature of the [[external carotid artery]], but the patient did not have retinal vascular malformations.<ref name=":6">{{cite journal|last1=Lester|first1=Jacobo|last2=Ruano-Calderon|first2=Luis Angel|last3=Gonzalez-Olhovich|first3=Irene|title=Wyburn-Mason Syndrome|journal=Journal of Neuroimaging|date=July 2005|volume=15|issue=3|pages=284–285|doi=10.1111/j.1552-6569.2005.tb00324.x}}</ref> | The treatment for Bonnet–Dechaume–Blanc syndrome is controversial due to a lack of consensus on the different therapeutic procedures for treating arteriovenous malformations.<ref name=":7">{{cite journal|last1=Schmidt|first1=D|last2=Pache|first2=M|last3=Schumacher|first3=M|title=The congenital unilateral retinocephalic vascular malformation syndrome (bonnet-dechaume-blanc syndrome or wyburn-mason syndrome): review of the literature.|journal=Survey of ophthalmology|date=2008|volume=53|issue=3|pages=227–49|pmid=18501269}}</ref> The first successful treatment was performed by Morgan et al.<ref name=":8">{{cite journal|last1=Bhattacharya|first1=JJ|last2=Luo|first2=CB|last3=Suh|first3=DC|last4=Alvarez|first4=H|last5=Rodesch|first5=G|last6=Lasjaunias|first6=P|title=Wyburn-Mason or Bonnet-Dechaume-Blanc as Cerebrofacial Arteriovenous Metameric Syndromes (CAMS). A New Concept and a New Classification.|journal=Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences|date=30 March 2001|volume=7|issue=1|pages=5–17|pmid=20663326}}</ref> They combined intracranial resection, ligation of ophthalmic artery, and selective arterial ligature of the [[external carotid artery]], but the patient did not have retinal vascular malformations.<ref name=":6">{{cite journal|last1=Lester|first1=Jacobo|last2=Ruano-Calderon|first2=Luis Angel|last3=Gonzalez-Olhovich|first3=Irene|title=Wyburn-Mason Syndrome|journal=Journal of Neuroimaging|date=July 2005|volume=15|issue=3|pages=284–285|doi=10.1111/j.1552-6569.2005.tb00324.x}}</ref> | ||
If lesions are present, they are watched closely for changes in size. Prognosis is best when lesions are less than 3 cm in length. Most complications occur when the lesions are greater than 6 cm in size.<ref name=":0" /> Surgical intervention for intracranial lesions has been done successfully. Nonsurgical treatments include [[embolization]], radiation therapy, and continued observation.<ref name=":3" /> Arterial vascular malformations may be treated with the [[cyberknife]] treatment. Possible treatment for cerebral arterial vascular malformations include stereotactic radiosurgery, endovascular embolization, and microsurgical resection.<ref name=":0" /> | If lesions are present, they are watched closely for changes in size. Prognosis is best when lesions are less than 3 cm in length. Most complications occur when the lesions are greater than 6 cm in size.<ref name=":0">{{cite journal|last1=SINGH|first1=A|last2=RUNDLE|first2=P|last3=RENNIE|first3=I|title=Retinal Vascular Tumors|journal=Ophthalmology Clinics of North America|date=March 2005|volume=18|issue=1|pages=167–176|doi=10.1016/j.ohc.2004.07.005|url=http://www.ophthalmology.theclinics.com/article/S0896-1549(04)00088-4/fulltext}}</ref> Surgical intervention for intracranial lesions has been done successfully. Nonsurgical treatments include [[embolization]], radiation therapy, and continued observation.<ref name=":3">{{cite journal|last1=Dayani|first1=P. N.|last2=Sadun|first2=A. A.|title=A case report of Wyburn-Mason syndrome and review of the literature|journal=Neuroradiology|date=18 January 2007|volume=49|issue=5|pages=445–456|doi=10.1007/s00234-006-0205-x}}</ref> Arterial vascular malformations may be treated with the [[cyberknife]] treatment. Possible treatment for cerebral arterial vascular malformations include stereotactic radiosurgery, endovascular embolization, and microsurgical resection.<ref name=":0" /> | ||
When pursuing treatment, it is important to consider the size of the malformations, their locations, and the neurological involvement.<ref name=":6" /> Because it is a congenital disorder, there are not preventative steps to take aside from regular follow ups with a doctor to keep an eye on the symptoms so that future complications are avoided. | When pursuing treatment, it is important to consider the size of the malformations, their locations, and the neurological involvement.<ref name=":6" /> Because it is a congenital disorder, there are not preventative steps to take aside from regular follow ups with a doctor to keep an eye on the symptoms so that future complications are avoided. | ||
Revision as of 17:13, 4 June 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Jyostna Chouturi, M.B.B.S [2]
Synonyms and keywords: Wyburn mason's syndrome; Retinoencephalofacial angiomatosis
Overview
.
Signs and symptoms
Causes
Mechanism
Epidemiology
Diagnosis
Treatment
The treatment for Bonnet–Dechaume–Blanc syndrome is controversial due to a lack of consensus on the different therapeutic procedures for treating arteriovenous malformations.[1] The first successful treatment was performed by Morgan et al.[2] They combined intracranial resection, ligation of ophthalmic artery, and selective arterial ligature of the external carotid artery, but the patient did not have retinal vascular malformations.[3]
If lesions are present, they are watched closely for changes in size. Prognosis is best when lesions are less than 3 cm in length. Most complications occur when the lesions are greater than 6 cm in size.[4] Surgical intervention for intracranial lesions has been done successfully. Nonsurgical treatments include embolization, radiation therapy, and continued observation.[5] Arterial vascular malformations may be treated with the cyberknife treatment. Possible treatment for cerebral arterial vascular malformations include stereotactic radiosurgery, endovascular embolization, and microsurgical resection.[4]
When pursuing treatment, it is important to consider the size of the malformations, their locations, and the neurological involvement.[3] Because it is a congenital disorder, there are not preventative steps to take aside from regular follow ups with a doctor to keep an eye on the symptoms so that future complications are avoided.
References
- ↑ Schmidt, D; Pache, M; Schumacher, M (2008). "The congenital unilateral retinocephalic vascular malformation syndrome (bonnet-dechaume-blanc syndrome or wyburn-mason syndrome): review of the literature". Survey of ophthalmology. 53 (3): 227–49. PMID 18501269.
- ↑ Bhattacharya, JJ; Luo, CB; Suh, DC; Alvarez, H; Rodesch, G; Lasjaunias, P (30 March 2001). "Wyburn-Mason or Bonnet-Dechaume-Blanc as Cerebrofacial Arteriovenous Metameric Syndromes (CAMS). A New Concept and a New Classification". Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 7 (1): 5–17. PMID 20663326.
- ↑ 3.0 3.1 Lester, Jacobo; Ruano-Calderon, Luis Angel; Gonzalez-Olhovich, Irene (July 2005). "Wyburn-Mason Syndrome". Journal of Neuroimaging. 15 (3): 284–285. doi:10.1111/j.1552-6569.2005.tb00324.x.
- ↑ 4.0 4.1 SINGH, A; RUNDLE, P; RENNIE, I (March 2005). "Retinal Vascular Tumors". Ophthalmology Clinics of North America. 18 (1): 167–176. doi:10.1016/j.ohc.2004.07.005.
- ↑ Dayani, P. N.; Sadun, A. A. (18 January 2007). "A case report of Wyburn-Mason syndrome and review of the literature". Neuroradiology. 49 (5): 445–456. doi:10.1007/s00234-006-0205-x.